• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于偏好的青光眼特异性健康相关生活质量量表:青光眼健康效用的开发。

Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma.

机构信息

Department of Health Research Methods, Evidence, and Impact.

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto.

出版信息

J Glaucoma. 2018 Jul;27(7):585-591. doi: 10.1097/IJG.0000000000000984.

DOI:10.1097/IJG.0000000000000984
PMID:29762270
Abstract

PURPOSE

To develop a descriptive system for a glaucoma-specific preference-based health-related quality of life (HRQoL) instrument: the Health Utility for Glaucoma (HUG-5).

METHODS

The descriptive system was developed in 2 stages: item identification and item selection. A systematic literature review of HRQoL assessment of glaucoma was conducted using a comprehensive search strategy. Purposeful sampling was used to recruit patients with different clinical characteristics. Relevant items were presented to glaucoma patients through face-to-face, semistructured interviews. Framework methodology was applied to analyze interview content. The recurring themes identified through an iterative content analysis represented topics of most importance and relevance to patients. These themes formed the domains of the HUG-5 descriptive system. Three versions of the descriptive system, differing in explanatory detail, were pilot tested using a focus group.

RESULTS

The literature review identified 19 articles which contained 266 items. These items were included for the full-text review and were used to develop an interview guide. From 12 patient interviews, 22 themes were identified and grouped into 5 domains that informed the 5 questions of the descriptive system. The HUG-5 measures visual discomfort, mobility, daily life activities, emotional well-being, and social activities. Each question has 5 response levels that range from "no problem" to "severe problem." The focus group comprised 7 additional patients unanimously preferred the version that contained detailed, specific examples to support each question.

CONCLUSIONS

A 5-domain descriptive system of a glaucoma-specific preference-based instrument, the HUG-5, was developed and remains to be evaluated for validity and reliability in the glaucoma patient population.

摘要

目的

开发一种用于特定于青光眼的偏好健康相关生活质量(HRQoL)工具的描述性系统:青光眼健康效用(HUG-5)。

方法

描述性系统分两个阶段开发:项目识别和项目选择。使用全面的搜索策略对青光眼的 HRQoL 评估进行了系统文献回顾。采用有目的抽样招募具有不同临床特征的患者。通过面对面、半结构化访谈向青光眼患者呈现相关项目。应用框架方法分析访谈内容。通过迭代内容分析确定的反复出现的主题代表了对患者最重要和最相关的主题。这些主题构成了 HUG-5 描述性系统的领域。使用焦点小组对 3 个不同解释详细程度的描述性系统版本进行了试点测试。

结果

文献综述确定了包含 266 个项目的 19 篇文章。这些项目被纳入全文审查,并用于开发访谈指南。通过对 12 名患者的访谈,确定了 22 个主题,并将其分为 5 个领域,为描述性系统的 5 个问题提供信息。HUG-5 衡量视觉不适、移动性、日常生活活动、情绪健康和社会活动。每个问题有 5 个回答级别,从“没有问题”到“严重问题”。焦点小组由另外 7 名患者组成,他们一致更喜欢包含详细、具体示例以支持每个问题的版本。

结论

开发了一种特定于青光眼的基于偏好的仪器的 5 域描述性系统,即 HUG-5,该系统仍需在青光眼患者群体中进行有效性和可靠性评估。

相似文献

1
Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma.基于偏好的青光眼特异性健康相关生活质量量表:青光眼健康效用的开发。
J Glaucoma. 2018 Jul;27(7):585-591. doi: 10.1097/IJG.0000000000000984.
2
Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation.基于疾病特异性偏好的青光眼健康状态衡量指标:HUG-5 心理测量学验证。
J Glaucoma. 2019 Jul;28(7):593-600. doi: 10.1097/IJG.0000000000001267.
3
Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters.为青光眼专用题库确定用于测量生活质量参数的内容。
J Glaucoma. 2015 Jan;24(1):12-9. doi: 10.1097/IJG.0b013e318287ac11.
4
Preference-based disease-specific health-related quality of life instrument for glaucoma: a mixed methods study protocol.基于偏好的青光眼疾病特异性健康相关生活质量量表:一项混合方法研究方案
BMJ Open. 2016 Nov 8;6(11):e012732. doi: 10.1136/bmjopen-2016-012732.
5
[Creating a specific quality-of-life questionnaire in patients with glaucoma: item generation].[创建青光眼患者特定生活质量问卷:条目生成]
J Fr Ophtalmol. 2002 Oct;25(8):785-94.
6
China Health Related Outcomes Measures (CHROME): development of a descriptive system to support cardiovascular disease specific preference-based measure for the Chinese population.中国健康相关结局测量(CHROME):开发描述性系统,以支持中国人群心血管疾病特异性偏好测量。
Qual Life Res. 2023 Sep;32(9):2463-2476. doi: 10.1007/s11136-023-03416-y. Epub 2023 Apr 29.
7
Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire.开发一种针对终末期肾病的健康相关生活质量测量方法:选择健康体验问卷。
Am J Kidney Dis. 2001 Jan;37(1):11-21. doi: 10.1053/ajkd.2001.20631.
8
Developing an Item Bank to Measure Quality of Life in Individuals With Glaucoma, and the Results of the Interview With Patients: The Effect of Visual Function, Visual Field Progression Rate, Medical, and Surgical Treatments on Quality of Life.开发一个用于测量青光眼患者生活质量的题库,以及患者访谈结果:视觉功能、视野进展率、药物和手术治疗对生活质量的影响。
J Glaucoma. 2017 Feb;26(2):e64-e73. doi: 10.1097/IJG.0000000000000554.
9
Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire.青光眼患者健康相关生活质量的测量:Glau-QoL 36项问卷的验证
Acta Ophthalmol. 2008 Feb;86(1):71-80. doi: 10.1111/j.1600-0420.2007.00999.x. Epub 2007 Aug 28.
10
The Visual Function Questionnaire: Utility Index: Does It Measure Glaucoma-related Preference-based Status?视觉功能问卷:效用指数:它能测量与青光眼相关的基于偏好的状态吗?
J Glaucoma. 2016 Oct;25(10):822-829. doi: 10.1097/IJG.0000000000000441.

引用本文的文献

1
Utility index and vision-related quality of life in patients awaiting specialist eye care.等待专科眼科治疗的患者的效用指数和与视力相关的生活质量。
PLoS One. 2024 Aug 12;19(8):e0307691. doi: 10.1371/journal.pone.0307691. eCollection 2024.
2
Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities.评估伴有和不伴有躯体或精神共病的青光眼患者的医疗负担。
J Manag Care Spec Pharm. 2020 Mar;26(3):325-331. doi: 10.18553/jmcp.2020.26.3.325.